Can Antihistamines Be Given to Children Under 2 Years?
Second-generation antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine) can be safely given to children under 2 years for allergic conditions, but first-generation antihistamines and OTC cough/cold combination products should be avoided due to significant toxicity risk.
Critical Distinction: Type of Antihistamine Matters
The answer depends entirely on which class of antihistamine you're considering:
First-Generation Antihistamines (AVOID)
- Do NOT use first-generation antihistamines (diphenhydramine, brompheniramine, chlorpheniramine) in children under 2 years 1
- Between 1969-2006, there were 69 fatalities associated with these three antihistamines in children ≤6 years, with 41 deaths occurring in children under 2 years 1
- Deaths resulted from overdose, medication errors, use of multiple products simultaneously, and accidental exposures 1
- Major manufacturers voluntarily removed OTC cough/cold products containing these antihistamines for children under 2 years in October 2007 1
Second-Generation Antihistamines (SAFE)
These ARE appropriate for children under 2 years:
- Cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine have demonstrated excellent safety profiles in young children 1
- Cetirizine is FDA-approved in the USA for children ≥6 months and in Europe for children ≥2 years 2
- A randomized, double-blind, placebo-controlled study specifically documented cetirizine safety in infants 6-11 months, showing no CNS or cardiac adverse effects 3
- Levocetirizine has been extensively studied in children as young as 6 months with no clinically relevant adverse effects on physical, psychomotor development, or laboratory parameters over 18 months 4
Clinical Application Algorithm
For allergic rhinitis or urticaria in children under 2 years:
First-line: Use a second-generation antihistamine
- Cetirizine 0.25 mg/kg twice daily (ages 6-11 months) 3
- Follow age-specific dosing for other second-generation agents
Avoid completely:
- Any OTC cough/cold combination products
- First-generation antihistamines (diphenhydramine, brompheniramine, chlorpheniramine)
- Antihistamine-decongestant combinations 1
For allergic rhinitis specifically:
- Consider intranasal corticosteroids as more effective alternative (though administration may be challenging in this age group)
Critical Safety Considerations
Common pitfalls to avoid:
- Never use multiple products simultaneously - this was a major cause of fatal overdoses 1
- Do not use for common cold symptoms - antihistamines are ineffective for viral upper respiratory infections in young children and lack proven benefit 1, 5
- Distinguish the indication: Second-generation antihistamines are appropriate for true allergic conditions (allergic rhinitis, urticaria), NOT for treating cough/cold symptoms 1, 5
Evidence Quality
The guideline evidence 1 from the Journal of Allergy and Clinical Immunology (2008) represents the highest-quality source, explicitly stating that second-generation antihistamines "have been shown to be well tolerated and to have a very good safety profile" in young children, while simultaneously documenting the mortality risk with first-generation agents. This is reinforced by dedicated pediatric safety studies 3 and recent reviews 5, 6.
The FDA currently does not recommend OTC cough and cold products containing antihistamines or decongestants in children under 2 years 5, but this applies to combination products and first-generation agents, not prescription second-generation antihistamines used for appropriate allergic indications.